AVEVA Group (LON:AVV) Rating Reiterated by UBS Group

Share on StockTwits

UBS Group reissued their neutral rating on shares of AVEVA Group (LON:AVV) in a report published on Wednesday morning, ThisIsMoney.Co.Uk reports.

Several other equities research analysts also recently issued reports on AVV. JPMorgan Chase & Co. raised their price target on AVEVA Group from GBX 3,550 ($46.39) to GBX 4,200 ($54.88) and gave the company an overweight rating in a report on Friday, October 25th. Barclays reissued an overweight rating on shares of AVEVA Group in a report on Thursday, October 10th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus price target of GBX 3,685 ($48.15).

Shares of AVEVA Group stock opened at GBX 4,248 ($55.51) on Wednesday. The business has a fifty day simple moving average of GBX 3,889.48 and a two-hundred day simple moving average of GBX 3,759.62. AVEVA Group has a 1 year low of GBX 2,264 ($29.58) and a 1 year high of GBX 4,250 ($55.53). The company has a market capitalization of $6.86 billion and a price-to-earnings ratio of 203.25. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.38 and a quick ratio of 1.30.

AVEVA Group Company Profile

AVEVA Group Plc, through its subsidiaries, provides engineering and industrial software for process and hybrid industries in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It provides solutions covering various aspects of the asset life cycle, including conceptual modeling and 3D design, process simulation, optimization, and manufacturing operations management.

Featured Story: NASDAQ

Analyst Recommendations for AVEVA Group (LON:AVV)

Receive News & Ratings for AVEVA Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVEVA Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.